Ozempic maker Novo Nordisk is shaking up its board.
www.marketwatch.com
#Ozempic #maker #shakes #board #year #turmoil #Novo #Nordisk
Related Posts

Deal, delay or strike? Investors on edge as Trump’s Iran deadline nears
April 7 (Reuters) – Global markets have entered a period of heightened uncertainty ahead of a deadline set by U.S.…

Virax Biolabs (VRAX) Falls 18% on Lack of Leads
We recently published 10 Stocks Losing Big. Virax Biolabs Group Ltd. (NASDAQ:VRAX) is one of the worst performers of Tuesday.…

3 Things to Watch With TGT Stock in 2026
Analysts sea a return to top- and bottom-line growth for Target in 2026. Keeping its yield high and its Dividend…

